ST- Depression on Electrocardiogram During Caesarean Section in Regional Anaesthesia in Women With Preeclampsia
NCT ID: NCT01530230
Last Updated: 2012-02-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2005-11-30
2008-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiac Effects of Oxytocin Administrated During Cesarean Section, Signs of Myocardial Ischemia
NCT00777166
Oxytocin And Uterotonic Agent Use For Cesarean Delivery
NCT01549223
Pharmacokinetics of Oxytocin at Cesarean Delivery
NCT03898882
Oxytocin Induction in Full Term Pregnant Women With Cesarean Section of Prelabor Rupture of Membranes
NCT05333731
Oxytocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2
NCT03957083
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In a double-blind randomized controlled study preeclamptic patients undergoing cesarean section under spinal anesthesia were randomized to 5 or 10 units of oxytocin, given as an intravenous bolus. A Holter monitor was used to record electrocardiograms. Non-invasive blood pressure and heart rate were monitored.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oxytocin 5 units
oxytocin
Intravenous bolus dose given during 1 minute after clamping of the umbilical cord
Oxytocin 10 units
oxytocin
Intravenous bolus dose given during 1 minute after clamping of the umbilical cord
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
oxytocin
Intravenous bolus dose given during 1 minute after clamping of the umbilical cord
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* obesity (body mass index \> 35),
* age \< 18 years,
* complications of the pregnancy other than preeclampsia or non-proficiency in the Swedish language
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uppsala University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maria Jonsson
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Obsterics and Gynecology
Uppsala, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2004-74
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.